191 related articles for article (PubMed ID: 10645679)
1. COX-2 selective NSAIDs.
Ryan NS
Cleve Clin J Med; 2000 Jan; 67(1):67. PubMed ID: 10645679
[No Abstract] [Full Text] [Related]
2. Aspirin and its rivals. As your options increase, your choices get harder.
Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
[No Abstract] [Full Text] [Related]
3. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of aspirin compromised by other NSAIDs.
Gottlieb S
BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958094
[No Abstract] [Full Text] [Related]
5. [Aspirin and prevention of cardiovascular risk].
Karila-Cohen D; Gabriel Steg P
Rev Med Interne; 2000 Mar; 21 Suppl 1():35s-40s. PubMed ID: 10763203
[TBL] [Abstract][Full Text] [Related]
6. An international scientific meeting on aspirin is needed.
Morgan G
J Epidemiol Community Health; 2003 May; 57(5):314. PubMed ID: 12700207
[No Abstract] [Full Text] [Related]
7. [Platelet antiaggregants].
Reverter JC
Med Clin (Barc); 2000 Jul; 115(6):214-5. PubMed ID: 11002460
[No Abstract] [Full Text] [Related]
8. Aspirin and cyclooxygenase-2 inhibitors.
Armstrong TA
Am J Health Syst Pharm; 2003 Jul; 60(14):1481. PubMed ID: 12892035
[No Abstract] [Full Text] [Related]
9. [Aspirin. A wonder drug?].
Diez-Ewald M
Invest Clin; 1997 Jun; 38(2):59-61. PubMed ID: 9296640
[No Abstract] [Full Text] [Related]
10. [A 100 years of aspirin: a drug with a future?].
Sánchez García P
An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
[No Abstract] [Full Text] [Related]
11. Cardiovascular events and COX-2 inhibitors.
McGeer PL; McGeer EG; Yasojima K
JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735747
[No Abstract] [Full Text] [Related]
12. [Immortal aspirin....].
Devulder B
Rev Med Interne; 2000 Mar; 21 Suppl 1():5s-7s. PubMed ID: 10763199
[No Abstract] [Full Text] [Related]
13. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
Hohlfeld T; Saxena A; Schrör K
Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
[TBL] [Abstract][Full Text] [Related]
14. What are all the things that aspirin does?
Flower R
BMJ; 2003 Sep; 327(7415):572-3. PubMed ID: 12969898
[No Abstract] [Full Text] [Related]
15. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
Strand V
Lancet; 2007 Dec; 370(9605):2138-51. PubMed ID: 18156036
[TBL] [Abstract][Full Text] [Related]
16. Aspirin resistance: does it exist and is it an important clinical problem?
Eikelboom J
Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
[No Abstract] [Full Text] [Related]
17. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
18. Aspirin for the second hundred years: new uses for an old drug.
Vainio H; Morgan G
Pharmacol Toxicol; 1997 Oct; 81(4):151-2. PubMed ID: 9353843
[TBL] [Abstract][Full Text] [Related]
19. The coxibs, selective inhibitors of cyclooxygenase-2.
Rich SA
N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657
[No Abstract] [Full Text] [Related]
20. Cardiovascular events and COX-2 inhibitors.
Singh G
JAMA; 2001 Dec; 286(22):2810-1; author reply 2811-2. PubMed ID: 11735748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
